Healthcare provider profile · identity verified

Robert T Plachy, M.D.

Family Practice · BROOKLYN, NY · NPI 1326397878

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	415	63
Atorvastatin Calcium	Atorvastatin Calcium	323	84
Pantoprazole Sodium	Pantoprazole Sodium	318	96
Potassium Chloride	Potassium Chloride	230	49
Furosemide	Furosemide	219	63
Amlodipine Besylate	Amlodipine Besylate	205	51
Metoprolol Tartrate	Metoprolol Tartrate	188	49
Sertraline Hcl	Sertraline Hcl	188	41
Levothyroxine Sodium	Levothyroxine Sodium	187	50
Tamsulosin Hcl	Tamsulosin Hcl	173	46
Famotidine	Famotidine	165	43
Donepezil Hcl	Donepezil Hcl	159	25
Spironolactone	Spironolactone	153	37
Mirtazapine	Mirtazapine	151	31
Quetiapine Fumarate	Quetiapine Fumarate	149	21
Metoprolol Succinate	Metoprolol Succinate	144	50
Simvastatin	Simvastatin	139	24
Losartan Potassium	Losartan Potassium	138	37
Trazodone Hcl	Trazodone Hcl	126	22
Clopidogrel	Clopidogrel Bisulfate	123	31
Januvia	Sitagliptin Phosphate	119	suppressed
Metformin Hcl	Metformin Hcl	110	25
Levetiracetam	Levetiracetam	94	12
Rosuvastatin Calcium	Rosuvastatin Calcium	93	26
Methenamine Hippurate	Methenamine Hippurate	89	29
Escitalopram Oxalate	Escitalopram Oxalate	84	23
Gabapentin	Gabapentin	79	26
Sucralfate	Sucralfate	72	14
Lisinopril	Lisinopril	68	19
Generlac	Lactulose	67	suppressed
Atenolol	Atenolol	64	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	63	suppressed
Hydralazine Hcl	Hydralazine Hcl	61	19
Xarelto	Rivaroxaban	61	13
Alendronate Sodium	Alendronate Sodium	60	13
Alprazolam	Alprazolam	57	23
Memantine Hcl	Memantine Hcl	57	suppressed
Allopurinol	Allopurinol	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	53	18
Latanoprost	Latanoprost	50	suppressed
Carvedilol	Carvedilol	47	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	44	14
Oxycodone Hcl	Oxycodone Hcl	43	34
Omeprazole	Omeprazole	42	18
Digoxin	Digoxin	41	12
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	41	17
Clonidine Hcl	Clonidine Hcl	40	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Risperidone Er	Risperidone Microspheres	39	suppressed
Midodrine Hcl	Midodrine Hcl	35	14
Cefpodoxime Proxetil	Cefpodoxime Proxetil	33	22
Ezetimibe	Ezetimibe	33	11
Tramadol Hcl	Tramadol Hcl	33	23
Primidone	Primidone	31	suppressed
Olanzapine	Olanzapine	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Divalproex Sodium	Divalproex Sodium	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Risperidone	Risperidone	28	suppressed
Torsemide	Torsemide	27	12
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Prednisone	Prednisone	26	17
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	12
Labetalol Hcl	Labetalol Hcl	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	18
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Trimethoprim	Trimethoprim	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Ramipril	Ramipril	20	suppressed
Lidocaine	Lidocaine	19	suppressed
Risperdal Consta	Risperidone Microspheres	19	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Azithromycin	Azithromycin	17	15
Warfarin Sodium	Warfarin Sodium	17	suppressed
Finasteride	Finasteride	16	suppressed
Zenpep	Lipase/Protease/Amylase	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Admelog	Insulin Lispro	14	suppressed
Aranesp	Darbepoetin Alfa In Polysorbat	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Colchicine	Colchicine	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nystatin	Nystatin	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	12
Dexamethasone	Dexamethasone	13	suppressed
Linzess	Linaclotide	13	suppressed
Loperamide	Loperamide Hcl	13	11
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Glipizide	Glipizide	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Mexiletine Hcl	Mexiletine Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error